Providing price limits and other requirements for health benefits covering prescription insulin drugs and establishing the insulin affordability program for the uninsured.

Summary

The bill forces health insurance policies issued after Jan. 1, 2027 to cover insulin and related devices, capping out‑of‑pocket costs at $35 for a month’s supply and $100 for devices. It also requires coverage of many insulin types, diabetes education, an appeals process, and rules on pharmacy benefit managers. The aim is to make insulin more affordable for insured Kansans and to set up an affordability program for the uninsured.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share